HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Occurrence of sulfated fucose branches in fucosylated chondroitin sulfate are essential for the polysaccharide effect preventing muscle damage induced by toxins and crude venom from Bothrops jararacussu snake.

Abstract
Snake envenoming is an important public health problem around the world, particularly in tropics. Beyond deaths, morbidity induced by snake venoms, such as myotoxicity, is of pivotal consequence to population. Bothrops jararacussu is the main venomous snake in southeast region of Brazil, and particularly presents strong myotoxic effect. The only available therapy, antibothropic antivenom, poorly affects venom-induced myotoxicity. The aim of this study is to assess the ability of fucosylated chondroitin sulfate (fucCS), a glycosaminoglycan with anticoagulant and antithrombotic properties, and its derivatives to inhibit toxic activities of B. jararacussu crude venom and its isolated toxins, named bothropstoxins (BthTX-I and BthTX-II). The in vitro myotoxic activities induced by crude venom, by BthTX-I alone and by toxins together were abolished by fucCS. Carboxyl reduction (fucCS-CR) kept this ability whereas defucosilation (defucCS) abrogates myoprotection. We observed the same pattern in the response of these polysaccharides in antagonizing the increase in plasma creatine kinase (CK) levels, the reduction of skeletal muscle CK content and the rise of myeloperoxidase (MPO) activity induced by crude venom and isolated toxins. FucCS inhibited edematogenic activity and partially prevented the reduction of total leukocytes in blood when pre-incubated with crude venom. Furthermore, the venom procoagulant effect was completely antagonized by increasing concentrations of fucCS, although this polyanion could stop neither the tail bleeding nor the skin hemorrhage induced by Bothrops jararaca venom. The B. jararacussu phospholipase, hyaluronidase, proteolytic and collagenase activities were inhibited in vitro. The results suggest that fucCS could be able to interact with both toxins, and it is able to inhibit BthTX-II phospholipase activity. Light microscopy of extensor digitorum longus muscle (EDL) muscle showed myoprotection by fucCS, once necrotic areas, edema and inflammatory cells were all decreased as compared to venom injection alone. Altogether, data show that fucCS was able to inhibit myotoxicity and inflammation induced by B. jararacussu venom and its phospholipase toxins, BthTX-I and BthTX-II. Thus, fucosylated chondroitin sulfate is a new polyanion with potential to be used as an adjuvant in the treatment of snakebites in the future.
AuthorsMarcos Monteiro-Machado, Marcelo A Tomaz, Roberto J C Fonseca, Marcelo A Strauch, Bruno L Cons, Paula A Borges, Fernando C Patrão-Neto, Matheus S Tavares-Henriques, Jhonatha M Teixeira-Cruz, Sabrina Calil-Elias, Adélia C O Cintra, Ana Maria B Martinez, Paulo A S Mourão, Paulo A Melo
JournalToxicon : official journal of the International Society on Toxinology (Toxicon) Vol. 98 Pg. 20-33 (May 2015) ISSN: 1879-3150 [Electronic] England
PMID25702961 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Crotalid Venoms
  • fucosylated chondroitin sulfate
  • bothropstoxin
  • Fucose
  • Chondroitin Sulfates
  • Peroxidase
  • Creatine Kinase
  • Phospholipases
  • Group II Phospholipases A2
  • bothropstoxin II
  • Hyaluronoglucosaminidase
  • Collagenases
Topics
  • Animals
  • Bothrops
  • Brazil
  • Chondroitin Sulfates (pharmacology)
  • Collagenases (metabolism)
  • Creatine Kinase (antagonists & inhibitors, blood)
  • Crotalid Venoms (toxicity)
  • Edema (chemically induced, drug therapy)
  • Fucose (pharmacology)
  • Group II Phospholipases A2 (toxicity)
  • Hyaluronoglucosaminidase (antagonists & inhibitors, metabolism)
  • Leukocytes (metabolism)
  • Male
  • Mice
  • Muscle, Skeletal (drug effects, metabolism)
  • Peroxidase (metabolism)
  • Phospholipases (antagonists & inhibitors, metabolism)
  • Snake Bites (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: